Canine serum keratan sulfate and hyaluronate concentrations. Relationship to age and osteoarthritis.
Elevated serum levels of keratan sulfate (KS) and hyaluronate (HA) in patients with osteoarthritis (OA) have been reported. We measured KS and HA in dogs to determine if there was an elevation of these serum glycosaminoglycans in a canine model of OA. A single intraarticular injection of 1 mg of chymopapain into a shoulder joint increased serum KS by tenfold, and HA by less than twofold, in 24 hours. Serum KS and HA levels were 3-5-fold higher in dogs younger than 2 months of age than in older dogs. Serum KS and HA concentrations and synovial fluid KS concentrations were unrelated to spontaneous cartilage degeneration in 1-year-old dogs. Higher KS levels in synovial fluid correlated with higher KS levels in serum (r = 0.54, P less than 0.025). The mean KS concentration in sera of older dogs (greater than 3 years old) with OA was 37% higher than that in disease-free controls, but the difference between the groups was not statistically significant. Thus, elevated levels of serum KS and HA do not appear to have clinical significance in this model of OA.
Leipold
H R
HR
James A. Baker Institute for Animal Health, New York State College of Veterinary Medicine, Cornell University, Ithaca 14853.
Goldberg
R L
RL
Lust
G
G
D000375:Aging / Q000097:blood*; D000818:Animals; D002917:Chymopapain / Q000494:pharmacology; D004285:Dogs; D005260:Female; D006025:Glycosaminoglycans / Q000097:blood*; D006820:Hyaluronic Acid / Q000097:blood*; D007632:Keratan Sulfate / Q000097:blood*; D008297:Male; D015207:Osteoarthritis, Hip / Q000097:blood*; D011237:Predictive Value of Tests; D012785:Shoulder Joint / Q000187:drug effects / Q000378:metabolism; D013582:Synovial Fluid / Q000032:analysis / Q000187:drug effects
D006025:Glycosaminoglycans; D006820:Hyaluronic Acid; D007632:Keratan Sulfate; D002917:Chymopapain